# Cybersecurity execution closure 0.6.6

## Scope
This closure records the software/QMS cybersecurity evidence available for the 0.6.6 freeze. It is an internal technical validation closure only and is not a medical, regulatory, or clinical authorization.

## Evidence disposition
- Vulnerability scan evidence: `qms/security/SAST_RESULTS.md`, `qms/security/VULNERABILITY_DISPOSITION_REGISTER.csv`, and `qms/security/SBOM.cyclonedx.json` are present for static analysis, vulnerability disposition, and dependency inventory.
- Threat model review evidence: prior threat-model records remain indexed, and 0.6.6 closure treats the 0.6.6 security controls as reviewed against replay, tamper, unsigned-update, and unauthorized clinical/human-use unlock paths.
- Penetration-test disposition: no external penetration test is claimed. Internal adversarial coverage is limited to replay/tamper/secure-update tests and static evidence; external penetration testing remains a post-freeze independent validation item.
- Residual clinical claim boundary: cybersecurity evidence supports internal preclinical software readiness only. Advanced clinical or human-use cybersecurity claims remain blocked until independent penetration testing and named security review are completed.

## 0.6.6 internal closure result
Cybersecurity evidence is closed for the 0.6.6 internal software freeze with residual external-validation limitations explicitly retained. No human-use authorization is implied.
